Teva Pharmaceutical Industries Limited (TEV) - Total Liabilities

Latest as of March 2026: €31.81 Billion EUR ≈ $37.19 Billion USD

Based on the latest financial reports, Teva Pharmaceutical Industries Limited (TEV) has total liabilities worth €31.81 Billion EUR (≈ $37.19 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore TEV long-term investments to assets to see how much of total assets are deployed in long-term investments.

Teva Pharmaceutical Industries Limited - Total Liabilities Trend (2015–2025)

This chart illustrates how Teva Pharmaceutical Industries Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Teva Pharmaceutical Industries Limited.

Teva Pharmaceutical Industries Limited Competitors by Total Liabilities

The table below lists competitors of Teva Pharmaceutical Industries Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Telefonaktiebolaget LM Ericsson B ADR NASDAQ:ERIC	USA	$186.22 Billion
Samsung Life KO:032830	Korea	₩313.36 Trillion
United Airlines Holdings Inc NASDAQ:UAL	USA	$67.87 Billion
Trip.com Group Ltd ADR NASDAQ:TCOM	USA	$96.13 Billion
NTPC Limited NSE:NTPC	India	Rs3.39 Trillion
SSE PLC ADR LS-50 1 F:SCTA	Germany	€17.23 Billion
Honda Motor Co. Ltd F:HDMA	Germany	€21.81 Trillion
Bajaj Auto Limited NSE:BAJAJ-AUTO	India	Rs369.77 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Teva Pharmaceutical Industries Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Teva Pharmaceutical Industries Limited to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.01	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.87	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.79	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Teva Pharmaceutical Industries Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Teva Pharmaceutical Industries Limited (2015–2025)

The table below shows the annual total liabilities of Teva Pharmaceutical Industries Limited from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	€32.83 Billion ≈ $38.39 Billion	-2.30%
2024-12-31	€33.61 Billion ≈ $39.29 Billion	-4.94%
2023-12-31	€35.35 Billion ≈ $41.33 Billion	+0.11%
2022-12-31	€35.31 Billion ≈ $41.29 Billion	-3.04%
2021-12-31	€36.42 Billion ≈ $42.58 Billion	-7.98%
2020-12-31	€39.58 Billion ≈ $46.27 Billion	-6.67%
2019-12-31	€42.41 Billion ≈ $49.58 Billion	-5.53%
2018-12-31	€44.89 Billion ≈ $52.48 Billion	-13.46%
2017-12-31	€51.87 Billion ≈ $60.64 Billion	-10.41%
2016-12-31	€57.90 Billion ≈ $67.69 Billion	+138.20%
2015-12-31	€24.31 Billion ≈ $28.42 Billion	--

About Teva Pharmaceutical Industries Limited

F:TEV Germany Drug Manufacturers - Specialty & Generic

Market Cap

$38.93 Billion

€33.30 Billion EUR

Market Cap Rank

#789 Global

#170 in Germany

Share Price

€28.60

Change (1 day)

+4.00%

52-Week Range

€15.30 - €30.50

All Time High

€57.25